REDWOOD CITY, Calif.--(BUSINESS WIRE)--SentreHEART, Inc., the manufacturer of the LARIAT Suture Delivery Device, today announced that it has received approval for an Investigational Device Exemption ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
REDWOOD CITY, Calif., SentreHEART, Inc. announced that it has received CE Mark approval for the LARIAT Surgical Left Atrial Appendage (LAA) Suture Delivery Device. The LARIAT Surgical LAA device is a ...
The authors of a new study believe surgical excision is the more effective treatment option for polydactyly as it is completed in one visit, typically creates little scarring and rarely leaves painful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback